Showing results (191-200 of 390) with videos related to
Sort By:
Pageof 39
Neurology. Clinical Practice|June 23, 2022
Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple SclerosisAmber Salter, Gary Cutter, Ruth Ann Marrie, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.European Journal of Neurology|August 25, 2021
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosisDawn W Langdon, Davorka Tomic, Iris-Katharina Penner, et al.Methods (San Diego, Calif.)|May 3, 2003
Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytesPia Kivisäkk, Zhugong Liu, Corinna Trebst, et al.Plos One|May 24, 2011
Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosisRichard A Rudick, M R Sandhya Rani, Yaomin Xu, et al.Archives of Neurology|July 14, 2010
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-upRichard A Rudick, Jar-Chi Lee, Gary R Cutter, et al.Journal of Visualized Experiments : Jove|July 22, 2014
The Multiple Sclerosis Performance Test (MSPT): an iPad-based disability assessment toolRichard A Rudick, Deborah Miller, Francois Bethoux, et al.International Journal of MS Care|January 17, 2022
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple SclerosisAmber Salter, Robert J Fox, Gary Cutter, et al.European Journal of Neurology|December 20, 2021
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.Kidney International|September 24, 2025
Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritisLea Novak, Stacy D Hall, Gary Cutter, et al.Pageof 39